News | ASTRO | October 24, 2020

ASTRO's Exhibit Hall Only Day Draws Over 1,000 Attendees

Conference programming for ASTRO20 began today, and runs through October 29

Conference programming for ASTRO20 began today, and runs through October 29 #ASTRO20

October 24, 2020 — The American Society of Radiation Oncology's (ASTRO) 62nd Annual Meeting launched its Exhibit Hall Only Day yesterday, a new event one day before programming begins, to provide more time for attendees to network and interact with exhibitors. More than 1,000 attendees from 60 countries participated in Exhibit Hall Only Day yesterday, visiting our more than 110 exhibitors.

Traci Conley, regional account manager with Standard Imaging, Inc. shared, “This is absolutely amazing! I stopped in the lounge this morning and it seems everyone shares the opinion…this is engaging and user-friendly. Well done to the entire ASTRO team!”

“This has been a great experience and exceeds my expectations and past experience of a virtual meeting,” said Kelly Graber, Stryker senior program manager-Tradeshow.

“This virtual Exhibit Hall is one of the best platforms I've experienced this year, and we're pleased with the amount of exposure and access it has given us. The ASTRO team always organizes a great event with quality scientific content mixed with vendor participation and social activities to provide everyone with an exceptional experience each year,” said Melanie Benton, director, Marketing, at Mevion Medical Systems.

ASTRO20 runs October 24-28, 2020, via an interactive virtual platform. The meeting, Global Oncology: Radiation Therapy in a Changing World, will feature reports from the latest clinical trials; panels on global oncology, health disparities and the novel coronavirus; and an immersive attendee experience in a virtual convention center.

Originally planned as an on-site meeting in Miami, the ASTRO 2020 Annual Meeting was moved to a web-based platform due to safety concerns associated with the COVID-19 pandemic. Given the large volume of new science to be unveiled, the content will be available for 30 days after the meeting ends.

"Cancer doesn’t wait, even during a pandemic. With the health and safety of cancer patients in mind, we chose to invest in an interactive platform so that we can offer attendees a complete meeting experience,” said ASTRO President Thomas J. Eichler, M.D., FASTRO. “Attendees will be able to engage with each other on live video and chat platforms and access more than 2,500 abstracts. We will have live, on-demand and interactive sessions to showcase the latest research and best practices in cancer treatment. Recognizing that many meetings were cancelled or abbreviated this year, we enhanced our educational program and will have more than 200 hours of continuing medical education (CME) credits available for 30 days after the meeting ends.”

The meeting platform includes a digital rendering of the Miami Beach Convention Center that attendees can navigate to interact with other attendees and ASTRO leadership, visit networking lounges, participate in job interviews and attend live and on-demand sessions.

For more information: ASTRO20

Related Content

IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, and SCK CEN (Belgian Nuclear Research Center) announced a strategic R&D partnership to enable the production of Actinimum-225 (225Ac), a novel radioisotope which has significant potential in the treatment of cancer.
News | Radiation Oncology | September 17, 2021
September 17, 2021 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, a
Strategies to help guide nuclear radiology teams at various healthcare systems in 2021 and beyond
Feature | Nuclear Imaging | September 16, 2021 | By Staff of the American Society of Nuclear Cardiology (ASNC)
A year after COVID-19 turned the world upside do
Evaluation of therapeutic efficacy of drug candidates in preclinical oncology with positron emission tomography (PET)

Getty Images

Feature | PET Imaging | September 14, 2021 | By Todd Sasser, Ph.D.
With a wealth of landmark studies in Breast, Cervical, Melanoma, Prostate, Colorectal, Oesophagus, Endocrine and Lung cancer, the ESMO Congress 2021 is a clear demonstration that oncology research has once again gathered momentum after being temporarily stopped in its tracks by the outbreak of the virus

Getty Images

News | Radiation Oncology | September 13, 2021
September 13, 2021 — At the opening press conference of the ...
Plan to attend RSNA21 at McCormick Place Chicago, Nov. 28 – Dec. 2, 2021

Getty Images

News | RSNA | September 13, 2021
September 13, 2021 — The Radiological Society of North America (RSNA) today announced highlights of the Technical Exh
Comment letters on the 2022 physician fee schedule and Radiation Oncology Model urge CMS to scale back extreme cuts that jeopardize access to life-saving cancer treatments

Getty Images

News | ASTRO | September 09, 2021
September 9, 2021 — The American Society for Radiation Oncology (AS...

Image of a STING protein, courtesy of UCLA Jonsson Comprehensive Cancer Center

News | PET Imaging | September 08, 2021
September 8, 2021 — A new study from scientists at the UCLA Jonsso...